Literature DB >> 7960986

High-dose preoperative radiation and full thickness local excision: a new option for selected T3 distal rectal cancers.

M Mohiuddin1, G Marks, J Bannon.   

Abstract

PURPOSE: To assess the efficacy of high-dose preoperative radiation and full thickness local excision as an option for the management of selected distal rectal cancers. METHODS AND MATERIALS: Forty-eight patients with invasive distal rectal cancer have been treated with high-dose preoperative radiation (45-55 GY at 180 cGy/fx) followed 6 to 8 weeks later by full thickness local excision. Three groups of patients are included in this study. Group 1 (N = 15) Medically Compromised: patients with rectal cancers Stages T3 or > 3 cm in size and significant cardiorespiratory disease that precluded radical surgery. Group 2 (N = 18) Elective: patients suitable for local treatment by standard criteria (Stages < T2 and < 3 cm in size), and group 3 (N = 15) Staged: patients with Stages T3 or > 3 cm in size that postradiation were downstaged and met the criteria as in group 2. One patient in group 3 was found to be pathologically T3 following full thickness local excision and was converted to an abdominoperineal resection. Follow-up ranges from 6-96 months with a median of 40 months.
RESULTS: The overall 5-year actuarial survival for the whole group is 83.5% and local recurrence is 10%. The 5-year survival is 74%, 92%, and 88% for Groups 1, 2, and 3 and 90%, 89%, and 50% for postradiation pathologic stages T0/T1, T2, and T3, respectively. Local recurrence rate by treatment groups are 20%, 11%, and 0% for groups 1, 2, and 3 and 11%, 0%, and 67% for postradiation Stages T0/T1, T2, and T3, respectively. Surgical complications, primarily wound healing, were observed in five patients (10%). Four patients required a subsequent colostomy (three for recurrence and one for a rectovaginal fistula). Sphincter function as measured by Parks criteria was good/excellent in 88% of patients.
CONCLUSION: High-dose preoperative radiation and full thickness local excision appear to be a promising new option for the management of selected patients with invasive distal rectal cancers. Selected patients with Stage T3 cancers that as a result of preoperative radiation are downstaged and met the criteria for primary local therapy (T2 or less) appear to have an excellent survival with retained normal sphincter function following full thickness local excision.

Entities:  

Mesh:

Year:  1994        PMID: 7960986     DOI: 10.1016/0360-3016(94)90359-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

Review 1.  Transanal Endoscopic Microsurgery.

Authors:  Theodore John Saclarides
Journal:  Clin Colon Rectal Surg       Date:  2015-09

2.  A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial.

Authors:  Julio Garcia-Aguilar; Qian Shi; Charles R Thomas; Emily Chan; Peter Cataldo; Jorge Marcet; David Medich; Alessio Pigazzi; Samuel Oommen; Mitchell C Posner
Journal:  Ann Surg Oncol       Date:  2011-07-14       Impact factor: 5.344

3.  Long-term outcome of local excision after complete pathological response to neoadjuvant chemoradiation therapy for rectal cancer.

Authors:  Nidal Issa; Alejandro Murninkas; Eldad Powsner; Zeev Dreznick
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

4.  Local excision of T2 and T3 rectal cancers after downstaging chemoradiation.

Authors:  C J Kim; T J Yeatman; D Coppola; A Trotti; B Williams; J S Barthel; W Dinwoodie; R C Karl; J Marcet
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

5.  Is transanal endoscopic microsurgery (TEM) a valid treatment for rectal tumors?

Authors:  E Lezoche; M Guerrieri; A Paganini; F Feliciotti; F Di Pietrantonj
Journal:  Surg Endosc       Date:  1996-07       Impact factor: 4.584

Review 6.  Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial.

Authors:  B Rau; P Wust; P Hohenberger; J Löffel; M Hünerbein; C Below; J Gellermann; A Speidel; T Vogl; H Riess; R Felix; P M Schlag
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

7.  Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer.

Authors:  Glenda G Callender; Prajnan Das; Miguel A Rodriguez-Bigas; John M Skibber; Christopher H Crane; Sunil Krishnan; Marc E Delclos; Barry W Feig
Journal:  Ann Surg Oncol       Date:  2009-10-22       Impact factor: 5.344

8.  Transanal local excision for preoperative concurrent chemoradiation therapy for distal rectal cancer in selected patients.

Authors:  Chimin Park; Wooyong Lee; Sangah Han; Seonghyeon Yun; Ho-Kyung Chun
Journal:  Surg Today       Date:  2007-11-26       Impact factor: 2.549

9.  Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma.

Authors:  Isabelle Bedrosian; Miguel A Rodriguez-Bigas; Barry Feig; Kelly K Hunt; Lee Ellis; Steven A Curley; Jean Nicolas Vauthey; Marc Delclos; Christopher Crane; Nora Janjan; John M Skibber
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

10.  Potential benefits of integration of therapies with chemoradiation in rectal cancer.

Authors:  Christopher H Crane; Prajnan Das
Journal:  Gastrointest Cancer Res       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.